Blue Horseshoe Stocks: PZOO Follow-Up

Pazoo, Inc. PZOO

We’re touching base with PZOO once again this morning. We brought it into the fold last Monday while the stock was trading at a low of .0225 and not only has it brought us a couple of quality chances for swing trades, it has held its ground extremely well over the past week, and has begun to spike once again.

Over the few sessions prior, PZOO had toyed with resistance at the 200DMA (.0339), and yesterday it managed to close above that mark for the first time. As usual, moving forward, we want to see that previous resistance level hold as future support. We’ll want to see the stock maintain above a minimum of .0261. From where it stands now, we’re looking at the next key resistance points coming up at .05 and .065.

If you didn’t catch our initial report on PZOO last Monday, we suggest taking a look at that to learn about the company’s online health and wellness portal, as well as the involvement it has in the cannabis sector. >> View PZOO Report

There has been two new statements issued by the company over the past couple of days that we’ll pass along here:

Yesterday PZOO announced that it was a main sponsor at the Just Jersey Jazz and Food Truck Festival on Sunday October 19th at Horse Shoe Lake in Succasunna, New Jersey >>> Click to View PR

This morning we’ve learned that PZOO has increased its stake in the medical marijuana testing labs by 10%, effectively creating a controlling interest for itself in the company currently running the project >>> Click to View PR

Also, take a look at this video chart update we put together on PZOO:

For More Info Check Out PAZOO.COM

Extended Watchlist:
FCAU, CARA, UNIS, MEA, AKS, VSR

Blue Horseshoe Stocks: PBR, PTIE Updates, & More

Petroleo Brasiliero S.A. (Petrobras) PBR Options

Our long-time favorite options-trading target, PBR, after taking a significant beating over the past couple of weeks, finally found support in the 10.80’s and began to bounce back during yesterday’s session. It marked the lowest PPS we’ve witnessed since we first began watching this play. We’re also seeing a moderate gap-up in premarket trading this morning. We want to see it achieve higher lows and higher highs over the next few sessions to confirm the trend.

We’ve experienced many dips and rips with PBR over the roughly 7-month period we’ve been tracking it, and as we usually do in this situation, we’re going to attempt to take advantage of the recovery pattern we’re observing. For a specific idea, we want to radar the November 14th 12.00 Calls.

Pain Therapeutics, Inc. PTIE 

The huge gap down we noticed in the premarket yesterday is what drew us to include PTIE in our morning report. We mentioned that we’d monitor it for a eventual bounce and it came almost immediately. The stock saw a brief morning low of 1.61, and bounced back as high as 2.14 in the afternoon.

It marked a 33% intraday move, and intrigued us enough to want to continue watching as the week progresses.

The cause of the enormous gap-down was the nixing of an agreement the company had with Pfizer to develop and commercialize its Remoxy pain medication. It’s worth it to note that despite the huge setback, the stock came into this week with an analyst price target of 8.00/share.

Ascent Solar Technologies, Inc. ASTI

ASTI is one we’ve had an eye on for the past several weeks as it has searched out its own lows, and after reaching a bottom in the 1.40-range a couple of weeks ago, the stock has been making some nice strides to recover lost ground.

This morning the stock is gapping up over $2 on the heels of an early morning PR relating to a key milestone in a potentially lucrative Chinese joint venture.

Extended Watchlist:
DRYS, FRO, JNUG, WAVX, WMGIZ 

Blue Horseshoe Stocks: NVAX, NQ & More

Novavax, Inc. NVAX 

NVAX is the latest Ebola-related stock to catch our eye, and while the initial fear that was driving a lot of these plays has calmed as people realize that the virus doesn’t exactly spread like wildfire, there is much being made of efforts to find a working vaccine and NVAX is attempting to answer that call.

The company announced today that it had presented at the 8th Vaccine and ISV Conference in Philadelphia on Sunday on what was called the first Ebola Vaccine Candidate based on the 2014 Guinea strain that caused the current outbreak in West Africa.

The company said it expects to begin Phase I testing by December, so we’re going to add NVAX to our watchlists for the time being. Additionally, the stock is gapping up to the tune of 10% here in the premarket, and the chart appears to have the possibility of a Golden Cross in the making.

NQ Mobile, Inc. NQ

This is a play we’ve tracked continuously since late this spring. After witnessing a nice move back in July from the low $4-range to the mid-$7’s, the stock had been under general consolidation until it found and bounced off of support about 6 weeks ago. It has made a nice steady recovery from that point on, and is gaining more traction this morning as it gaps up in the premarket on the heels of a PR.

The mobile security has just company submitted the necessary back-filings to once again become fully compliant, and no anomalies or adverse findings were uncovered, which adds another dimension to this play.

We also like the space NQ operates in- with mobile devices permeating every aspect of the current culture, the need for mobile security services such as those provided by NQ only stands to grow in the future.

Side Note:
PTIE, DRRX (Two that are gapping down significantly; we will want to watch for an eventual bounce)

Extended Watchlist:
ISR, AEZS, TSEM, CEMI,

Blue Horseshoe Stocks: APT, VTAE, NEWC & More

Alpha Pro Tech Ltd. APT 

Here’s a past gainer that began to catch our attention yesterday- We jumped on APT for the first time back on October 10th, while the stock was in the middle of a huge run. We observed the low of 5.72 on that day, and the stock took just two more sessions to reach a high of 10.73, marking a move of 87%

Following that big spike, APT had been beaten back over the past couple weeks, and this week, has begun to bounce off support above the 50DMA (3.58). We want to pay attention as the stock attempts a recovery.

Vitae Pharma, Inc. VTAE

We want to put VTAE on our radar as we close out the week, and keep an eye on it moving forward. The stock is gapping up big this morning; it had already been on the incline prior to yesterday’s news that really served to heat things up.

VTAE announced it had received positive results from a couple of its Phase-1 trials for an Alzheimer’s treatment they claim “Demonstrated Greater Than 80% Reduction of an Alzheimer’s Disease Biomarker” >> VIEW PR

The statement indicated that the results would lead to further trials over the next several months, so we’re going to enter VTAE into the log and reserve it a spot on our watchlists.

New Columbia Resources, Inc. NEWC

NEWC is a play we want to radar and add to our expansive marijuana-stock watchlist. We’re always keeping our eyes peeled for new cannabis stocks to watch, and we caught this one on a news scan today.

The company announced that its “Colombian subsidiary, Sannabis S.A.S., has legally produced  a trial run of cannabis based products on an Indian reservation.”

Infinera Corp. INFN

INFN appeared in yesterday’s report and made a decent move on strong volume, to the tune of nearly 10X the monthly average. The stock traded in a range from 12.17-13.96, a 15% intraday increase. We’ll be keeping watch over this play into next week as well.

Extended Watchlist:
OMEX, HEB, RUBI, IBIO

Blue Horseshoe Stocks: Pot Stocks Take Off, Updates & More

Marijuana Sector Heating Up

We sincerely hope at least a few of our readers were able to take advantage of our perfectly-timed “Marijuana Sector Reminder” in yesterday’s morning report. Therein we reiterated an earlier warning we issued that the approaching voting season, increased judicial inquiry, and growing acceptance of cannabis could lead to another sectorwide surge.

We went as far as naming a few of our past winners we felt were prime candidates to bring us further opportunities: MJNA, CBIS, HEMP, GRNH, TRTC & ERBB, and we couldn’t have gone wrong with any of them. In a stroke of extreme good fortune, every single one of these plays was sent on a ride yesterday!

MJNA – Range: .155-.18 – Max Gain: 16%

CBIS – Range: .061-.074 – Max Gain: 21%

HEMP – Range: .036-.057 – Max Gain: 58%

GRNH – Range: .134-.225 – Max Gain: 68%

TRTC – Range: .321-.372 – Max Gain: 16%

ERBB – Range: .0167-.0209- Max Gain: 25%

CUMULATIVE TOTAL: +204%

We’re going to continue to keep an eye on the sector as volatility ramps up. We expect to see more good moves from these and other marijuana stocks over the next several weeks, so be sure to stay tuned to our coverage as we follow along with yet another exciting cannabis trend.

Pazoo, Inc. PZOO

PZOO continued to fare well on Wednesday, making positive strides in both PPS and volume each day this week since our initial report on Monday.

The stock began at a low of .0225 the first day, broke through its 50DMA trading as high as .031 on Tuesday, and yesterday it pushed its limits even further to .037. That marks a three-day overall increase of 64%

We were pleased to be updated yesterday morning on the build-out status of the marijuana testing facilities being set up by MA & Associates, in which PZOO is a 40% stakeholder. >>VIEW PR

Today, it announced the 3rd installment of Pazoo Radio as well, so in addition to a positive progression on the chart, the company has a lot going on in all other aspects as well, which is why we intend to stay hot on the trail of PZOO for the foreseeable future.

Image Sensing Systems, Inc. ISNS

On Tuesday, we tagged this play stating that we wanted to “reassign ISNS a spot on our speculative watchlist.” as a result of the activity we were seeing as it came off of a bottom. At the time, we observed a low of 2.31, and yesterday, the stock attained a high of 3.46.

That marks a 50% overnight turnaround, so big cheers go out to anyone who hopped on ISNS with us!

Extended Watchlist:
VSR(News), CYTX(FDA approval), JAKK, INFN, IGC, DRD

Get Our FREE Daily Reports!

SUBSCRIBE